Cancer Market Research Reports & Industry Analysis

... . “Global Breast Cancer Vaccine Market & Clinical Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the global breast cancer vaccine development market. Currently there is no single breast cancer vaccine commercially available in the market ...

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the German cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Italian cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

... opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Japanese cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

... business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the UK cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment ...

... , it is anticipated that the Global Cancer Cognitive Computing market will cross US$ 4 Billion by 2022. The growth of the market is likely to be driven by advancements in computing platforms, rising installation of cognitive computing software in hospitals, increasing large and complex genomic datasets, and growing cancer incidences. The report, “Global Cancer Cognitive Computing Market Outlook ...

... India Cervical Cancer Screening Market Outlook 2022” research report discusses all aspects related to the cervical cancer screening market in India. Report gives comprehensive insight on the current accessible cervical screening approaches available in India ...

... their potential applications for cancer diagnostic testing. Review of competing/complementing technologies. Companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Strategies Strategic assessments of major suppliers and start- up firms developing innovative cancer diagnostic technologies and ...

... expiry of blockbuster cancer drugs is another major factor which is propelling the growth of the cancer generics industry. As per RNCOS report “Global Cancer Generics Market Forecast to 2022”, the global cancer generics market is anticipated ... widely used type of cancer generics drugs. The report also highlights the major cancer generic drugs available in the global market. Furthermore, the global cancer generics market has also been ...

... , the Global Cancer Vaccines market is accounted for $2.25 billion in 2015 and is expected to reach $10.00 billion by 2022 growing at a CAGR of 23.7%. Factors such as rising number of cancer patients ... organisation and GAVI initiatives. Some of the key players in Global Cancer Vaccines market include Oxford BioMedica, Vaccinogen Inc., GlaxoSmithKline, Sanofi India Limited ...

... sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources ... co-morbid conditions on Prostate Cancer’s incident population. Identify sub-populations within Prostate Cancer which require treatment ...

... “Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer (2016-2020)”, provides analysis of the global cancer diagnostics market and the US cancer diagnostics market, with detailed analysis of market size and growth, penetration and market share. The report also provides the analysis of the global and ...

... with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). Some say novel therapies ... to evolve over the next five years in KOL Insight: Colorectal Cancer. You’ll get 12 North American and European KOLs’ candid thoughts on 6 recently marketed CRC treatments ...

According to Stratistics MRC, the Global Cancer Biomarkers market is estimated at $9215.32 million in 2015 and is expected to reach $20958.63 million by ... opportunity for the market growth. North America captured huge share in terms of revenue owing to raising awareness towards cancer diagnostics. However, Asia ...

... subsegments: Cancer Immunotherapy Market, by Type Monoclonal Antibodies Cancer Vaccines Checkpoint Inhibitors Immunomodulators Cancer Immunotherapy Market, by Application Lung Cancer Breast Cancer Head and Neck Cancer Prostate Cancer Colorectal Cancer Melanoma Others Cancer Immunotherapy Market, by End ...

... Breast Cancer Drug Market Outlook 2022” Report Highlights: US Breast Cancer Tendencies US Breast Cancer Drug Market Outline US Breast Cancer Drug Market Dynamics Breast Cancer Risk Undercurrents US Breast Cancer Marketed Drugs Clinical Insight by Company & Patent Analysis US Breast Cancer Marketed ...

... information sourced from the proprietary Epiomic patient segmentation database. To generate ... from patient registries, clinical trials and epidemiology studies. All of the sources used ... on the Non-melanoma skin cancer prevalent population. Identify sub-populations within Non-melanoma skin cancer which require ...

... MRC, the Global Cancer/Tumor Profiling market is expected to grow from $23.04 billion in 2015 to reach $78.69 billion by 2022 with a CAGR of 19.2%. Increasing cases of cancer and the need ... cancer profiling industry leaders. Asia Pacific is expected to witness huge growth due to raising incidence of cancer in this region. Some of the key players in global Cancer/Tumor profiling market ...

... 3 rival brands managed small barrier-related gains? Which barriers have the biggest impact on market share? Find out in Market Access Impact: NSCLC. Request sample pages ... ) Exploring Important Market Access Issues Market Access Impact: NSCLC explores key issues affecting NSCLC drug manufacturers. You’ll learn: How barriers affect market access: What brands ...

... barriers related to market access affect slightly more prescriptions than any other barrier. One brand has a small perception problem: 15% ... Exploring Market Access Barriers Market Access Impact: NSCLC explores key issues affecting NSCLC drug manufacturers. You’ll learn: How barriers affect market access: ...

... is cancer immunotherapy, particularly T-cell immunotherapy. T-cell immunotherapy has shown great promise in the treatment of patients with late-stage cancer. According to RNCOS’ new research report “T-Cell Immunotherapy for Cancer - Pipeline Analysis”, T-cell immunotherapy ...

... and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...

... the other top contributors to the global breast cancer screening population. iGATE RESEARCH report titled “Breast Cancer Screening (Mammography, MRI and Ultrasound) Market and Population Forecast to 2021 ... Breast Cancer Screening Population, Market and Forecast 2. Breast Cancer Mammography Screening Population and Forecast 3. Breast Cancer MRI and Ultrasound Screening Population and Forecast 4. Breast Cancer Mammography Screening Market and Forecast 5. Breast Cancer MRI Screening Market and Forec

... report, Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021), Global Cancer Diagnostics market is projected to exhibit a CAGR of over ~8.8% during 2016 - 2021. On the basis of market segment, Global Cancer Diagnostics Market has been ...

... .com provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market ...

... European oncologists to find out how satisfied they are with non-small cell lung cancer (NSCLC) drugs. Which brand outscored its nearest rival by almost ... higher the score the healthier the brand. What is FirstView NPS+? NPS+ turns your Net Promoter Score into actionable information by answering ...

... 100 US oncologists to find out how satisfied they are with non-small cell lung cancer (NSCLC) drugs. Which brand outscored its nearest rival by almost ... higher the score the healthier the brand. What is FirstView NPS+? NPS+ turns your Net Promoter Score into actionable information by answering ...

This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 80 pages

This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution ...

... technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics ...

... cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer ...

... , as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth ...

... in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Asia; ... Japan, Spain, UK, USA Worldwide Market Overview Five-year test volume and sales projections by country. Comprehensive market segmentation analysis, including review of the market ...

Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory Other Diseases This Competitive Intelligence report about Bispecific Antibodies for Cancer, Inflammatory Other Diseases evaluates the competitive ... as: T-Cell or NK cell redirecting bispecific cancer antibodies Bispecific immuno-oncology antibodies Bispecific tumor antigens targeted cancer antibodies Bispecific antibodies for inflammatory autoimmune diseases Bispecific antibodies for cardiometabolic, infectious, neurologic ...

... co-morbidities for Brain & CNS Cancer include: Genetic susceptibility Family history of brain & CNS ... and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate ... information from patient registries, clinical trials and epidemiology studies. All of the sources used to ...

... include surgery, chemotherapy, radiotherapy and targeted therapy. Global gastric cancer market is conspicuous by poor prognosis, because of the indolent ... cancer drugs. The report provides an overview of the entire market through global and regional analysis. Prevalence and market value of gastric cancer ...

... report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends ... applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and ...

... titled “Global Oncology Ablation Market Outlook: 2015-2020” provides in-depth analysis of oncology ablation market in four major geographies. The report also emphasizes on the current trends in oncology ablation, market size, market share ...

... Dendritic Cells New Vaccine Strategies That Exploit Dendritic Cells Biochemistry Dendritic Cell Cancer Vaccine Market & Clinical Insight Comparative Insight of Dendritic Cell Vaccines & Other Class of Vaccines Dendritic Cell Cancer Vaccine Pipeline by Country, Company, Indication & Phase Dendritic Cell Cancer ...

... Stomach Cancer include: History of stomach polyps or stomach lymphoma Family history of stomach cancer Family history of hereditary non-polyposis Colorectal cancer ... sourced from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the ...

... with nab-paclitaxel for patients with metastatic triple- negative breast cancer (mTNBC); the US Food and Drug Administration (FDA) awarding ... of this expanded indication have on prescriptions of Ibrance and on those of Afinitor? Update Bulletins include expert insight and analysis based on FirstWord analyst re- ...

... . Growing incidence of oncology diseases is expected to boost the demand for next generation cancer diagnostic tests market. However, lack of sufficient reimbursement policies for novel ... the global next generation cancer diagnostics market growth over the forecast period. The largest segment of the global market for next generation cancer diagnostics is Blood-born cancers. Asia ...

IMARC’s latest study “Generic Oncology Drug Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, ... of the generic oncology market and who are the key players? What are the key success factors for generic oncology drug manufacturers? How are generic oncology drugs manufactured ...

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives ... and market shares of major cancer diagnostic product suppliers in major countries by individual test. Five-year test volume and sales forecasts ...

This new 28-country survey from VPGMarketResearch.com contains over 925 pages and 366 tables. The survey is designed to assist diagnostics industry executives ... and market shares of major cancer diagnostic product suppliers in major countries by individual test Five-year test volume and sales forecasts ...

Global genomics in cancer care market is expected to reach USD 9.22 billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer coupled with adoption of next ...

... Peptide Cancer Vaccine Need of Peptide Cancer Vaccines Clinical Trials Efficacy Study of Synthetic Peptide Analog Obtained From WT1 Oncoprotein Wide Spectrum Action of Peptide Cancer Vaccines against Major Cancer Global Peptide Cancer Vaccine Pipeline: 41 Vaccines Global Peptide Cancer Vaccine ...

... Pancreatic Cancer include: • Obesity • Diabetes • Jaundice • Pancreatitis • Gallbladder enlargement This report is built using data and information sourced from the proprietary Epiomic ... to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the ...

... that have the potential to shape the targeted treatment of Non-Small Cell Lung Cancer (NSCLC). Topics covered include opinions about Tagrisso (osimertinib; ... Merck’s Keytruda as a second-line treatment for PD-L1 positive advanced NSCLC? Update Bulletins include expert insight and analysis based on FirstWord ...

... setting up a generic oncology drug manufacturing plant? How much income will the generic oncology drug manufacturing plant generate? What will be the profitability of the generic oncology drug manufacturing plant? What will be the NPV of the generic oncology drug manufacturing plant? What ...